Compare ACFN & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACFN | ARAY |
|---|---|---|
| Founded | 1986 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.1M | 39.3M |
| IPO Year | 2006 | 2006 |
| Metric | ACFN | ARAY |
|---|---|---|
| Price | $322.72 | $0.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | 48.6K | ★ 1.2M |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $4,350,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.58 |
| P/E Ratio | $224.78 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.42 | $0.22 |
| 52 Week High | $31.88 | $2.10 |
| Indicator | ACFN | ARAY |
|---|---|---|
| Relative Strength Index (RSI) | 65.94 | 49.35 |
| Support Level | $16.19 | $0.24 |
| Resistance Level | $21.26 | $0.29 |
| Average True Range (ATR) | 1.19 | 0.03 |
| MACD | 0.17 | -0.00 |
| Stochastic Oscillator | 100.00 | 22.35 |
Acorn Energy Inc is a holding company that focuses on technology-driven solutions for energy infrastructure asset management. The company operates through two segments namely, the PG segment and the CP segment. PG segment provides wireless remote monitoring and control systems and services for critical assets as well as Internet of Things applications which account for the majority of the revenue. CP segment is engaged in providing remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.